v3.26.3
Collaboration and License Agreements - BioMarin Pharmaceutical Inc (Details) - BioMarin Pharmaceutical, Inc. - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2024
Collaboration and License Agreements          
Deferred revenue         $ 1,000,000.0
Fixed consideration amount         $ 3,800,000
Research and collaboration revenue $ 0 $ 800,000 $ 100,000 $ 2,600,000